Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(1)
Other(2)

Detailed Status

unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

terminated133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
unknownnot_applicable

Evaluate the Efficacy and Safety of Glaucoma Implant in Primary Open Angle Glaucoma

NCT05892185
unknownnot_applicable

Evaluation of Minimal Invasive Glaucoma Surgery

NCT04572880
terminated

Effect of Xen Implantation on the Aqueous Humor Proteome

NCT04141865

Clinical Trials (3)

Showing 3 of 3 trials
NCT05892185Not Applicable

Evaluate the Efficacy and Safety of Glaucoma Implant in Primary Open Angle Glaucoma

Unknown
NCT04572880Not Applicable

Evaluation of Minimal Invasive Glaucoma Surgery

Unknown
NCT04141865

Effect of Xen Implantation on the Aqueous Humor Proteome

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3